Avanos Medical (AVNS) Other Non-Current Liabilities (2013 - 2026)

Avanos Medical has disclosed Other Non-Current Liabilities across 14 years of filings, most recently posting $14.1 million for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $14.1 million, up 213.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.1 million (up 213.33% YoY), and the FY2025 annual result was $13.5 million, up 206.82% from the prior year.
• Other Non-Current Liabilities came in at $14.1 million for Q1 2026 at Avanos Medical, up from $13.5 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $28.0 million in Q1 2022 to a low of $4.3 million in Q2 2025.
• The 5-year median for Other Non-Current Liabilities is $14.1 million (2026), against an average of $14.9 million.
• Across the five-year window, Other Non-Current Liabilities tumbled 59.05% in 2025 and jumped 213.33% in 2026, its largest moves.
• Avanos Medical's Other Non-Current Liabilities stood at $20.5 million in 2022, then slumped by 51.22% to $10.0 million in 2023, then tumbled by 56.0% to $4.4 million in 2024, then jumped by 206.82% to $13.5 million in 2025, then advanced by 4.44% to $14.1 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $14.1 million (Q1 2026), $13.5 million (Q4 2025), and $20.7 million (Q3 2025), per Business Quant data.